Skip to main content
Erschienen in: European Archives of Oto-Rhino-Laryngology 12/2019

01.07.2019 | Head and Neck

Assessment of the relationship between polysomnography parameters and plasma malondialdehyde levels in patients with obstructive sleep apnea

verfasst von: Özden Savaş, Ahmet Emre Süslü, Incilay Lay, Serdar Özer

Erschienen in: European Archives of Oto-Rhino-Laryngology | Ausgabe 12/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The relationship of plasma malondialdehyde (MDA) with major parameters of PSG was investigated to find out if there was a correlation between these variables.

Methods

Polysomnograms were done on a total of 37 adults who do not have a history of any systemic illness, smoking, and supplement use. Plasma MDA measurements and their relationship with PSG parameters were analyzed.

Results

The mean MDA concentrations in patients with lower AHI values were also lower than those in the patients with higher AHI (p < 0.001). Higher predominance of apnea in patients with similar AHI values, longer mean apnea durations, O2 saturation dips to < 90%, and higher ODI values predicted higher plasma MDA concentrations.

Conclusions

Higher oxidative stress measurements predicted more severe clinical picture. These findings show that oxidative stress measurement with MDA may provide a simple tool to screen patients for OSA and help select them for PSG study appropriately, if indicated
Literatur
1.
Zurück zum Zitat Senaratna C, Perret J, Lodge C, Lowe A, Campbell B, Matheson M, Hamilton G, Dharmage S (2017) Prevalence of obstructive sleep apnea in the general population: a systematic review. Sleep Med Rev 34:70–81CrossRef Senaratna C, Perret J, Lodge C, Lowe A, Campbell B, Matheson M, Hamilton G, Dharmage S (2017) Prevalence of obstructive sleep apnea in the general population: a systematic review. Sleep Med Rev 34:70–81CrossRef
2.
Zurück zum Zitat Ramachandran S, Josephs L (2009) A meta-analysis of clinical screening tests for obstructive sleep apnea. Anesthesiology 110(4):928–939CrossRef Ramachandran S, Josephs L (2009) A meta-analysis of clinical screening tests for obstructive sleep apnea. Anesthesiology 110(4):928–939CrossRef
3.
Zurück zum Zitat Lavie L (2008) Intermittent hypoxia: the culprit of oxidative stress, vascular inflammation and dyslipidemia in obstructive sleep apnea. Expert Rev Respir Med 2(1):75–84CrossRef Lavie L (2008) Intermittent hypoxia: the culprit of oxidative stress, vascular inflammation and dyslipidemia in obstructive sleep apnea. Expert Rev Respir Med 2(1):75–84CrossRef
4.
Zurück zum Zitat Lavie L (2015) Oxidative stress in obstructive sleep apnea and intermittent hypoxia—revisited—the bad ugly and good: implications to the heart and brain. Sleep Med Rev 20:27–45CrossRef Lavie L (2015) Oxidative stress in obstructive sleep apnea and intermittent hypoxia—revisited—the bad ugly and good: implications to the heart and brain. Sleep Med Rev 20:27–45CrossRef
5.
Zurück zum Zitat Schwedhelm E (2004) Urinary 8-iso-Prostaglandin F2 as a Risk Marker in Patients With Coronary Heart Disease: A Matched Case-Control Study. Circulation 109(7):843–848CrossRef Schwedhelm E (2004) Urinary 8-iso-Prostaglandin F2 as a Risk Marker in Patients With Coronary Heart Disease: A Matched Case-Control Study. Circulation 109(7):843–848CrossRef
6.
Zurück zum Zitat Seet R, Lee C, Lim E, Tan J, Quek A, Chong W, Looi W, Huang S, Wang H, Chan Y (2010) Oxidative damage in Parkinson disease: measurement using accurate biomarkers. Free Radical Biol Med 48(4):560–566CrossRef Seet R, Lee C, Lim E, Tan J, Quek A, Chong W, Looi W, Huang S, Wang H, Chan Y (2010) Oxidative damage in Parkinson disease: measurement using accurate biomarkers. Free Radical Biol Med 48(4):560–566CrossRef
7.
Zurück zum Zitat Nadeem R, Molnar J, Madbouly E, Nida M, Aggarwal S, Sajid H, Naseem J, Loomba R (2013) Serum inflammatory markers in obstructive sleep apnea: a meta-analysis. J Clin Sleep Med 9(10):1003–1012PubMedPubMedCentral Nadeem R, Molnar J, Madbouly E, Nida M, Aggarwal S, Sajid H, Naseem J, Loomba R (2013) Serum inflammatory markers in obstructive sleep apnea: a meta-analysis. J Clin Sleep Med 9(10):1003–1012PubMedPubMedCentral
8.
Zurück zum Zitat De Luca Canto LG, Pachêco-Pereira C, Aydinoz S, Major P, Flores-Mir C, Gozal D (2015) Diagnostic capability of biological markers in assessment of obstructive sleep apnea: a systematic review and meta-analysis. J Clin Sleep Med 11(1):27–36PubMedPubMedCentral De Luca Canto LG, Pachêco-Pereira C, Aydinoz S, Major P, Flores-Mir C, Gozal D (2015) Diagnostic capability of biological markers in assessment of obstructive sleep apnea: a systematic review and meta-analysis. J Clin Sleep Med 11(1):27–36PubMedPubMedCentral
9.
Zurück zum Zitat Yamauchi M, Nakano H, Maekawa J, Okamoto Y, Ohnishi Y, Suzuki T, Kimura H (2005) Oxidative stress in obstructive sleep apnea. Chest 127(5):1674–1679CrossRef Yamauchi M, Nakano H, Maekawa J, Okamoto Y, Ohnishi Y, Suzuki T, Kimura H (2005) Oxidative stress in obstructive sleep apnea. Chest 127(5):1674–1679CrossRef
10.
Zurück zum Zitat Svatikova A, Wolk R, Lerman L, Juncos L, Greene E, McConnell J, Somers V (2005) Oxidative stress in obstructive sleep apnoea. Eur Heart J 26(22):2435–2439CrossRef Svatikova A, Wolk R, Lerman L, Juncos L, Greene E, McConnell J, Somers V (2005) Oxidative stress in obstructive sleep apnoea. Eur Heart J 26(22):2435–2439CrossRef
11.
Zurück zum Zitat Jordan W, Cohrs S, Degner D et al (2005) Evaluation of oxidative stress measurements in obstructive sleep apnea syndrome. J Neural Transm 113(2):239–254CrossRef Jordan W, Cohrs S, Degner D et al (2005) Evaluation of oxidative stress measurements in obstructive sleep apnea syndrome. J Neural Transm 113(2):239–254CrossRef
12.
Zurück zum Zitat Barceló A, Miralles C, Barbé F, Vila M, Pons S, Agustí A (2000) Abnormal lipid peroxidation in patients with sleep apnoea. Eur Respir J 16(4):644CrossRef Barceló A, Miralles C, Barbé F, Vila M, Pons S, Agustí A (2000) Abnormal lipid peroxidation in patients with sleep apnoea. Eur Respir J 16(4):644CrossRef
13.
Zurück zum Zitat Vatansever E, Surmen-Gur E, Ursavas A, Karadag M (2010) Obstructive sleep apnea causes oxidative damage to plasma lipids and proteins and decreases adiponectin levels. Sleep Breath 15(3):275–282CrossRef Vatansever E, Surmen-Gur E, Ursavas A, Karadag M (2010) Obstructive sleep apnea causes oxidative damage to plasma lipids and proteins and decreases adiponectin levels. Sleep Breath 15(3):275–282CrossRef
14.
Zurück zum Zitat Celec P, Hodosy J, Behuliak M, Pálffy R, Gardlík R, Halčák L, Mucska I (2011) Oxidative and carbonyl stress in patients with obstructive sleep apnea treated with continuous positive airway pressure. Sleep Breath 16(2):393–398CrossRef Celec P, Hodosy J, Behuliak M, Pálffy R, Gardlík R, Halčák L, Mucska I (2011) Oxidative and carbonyl stress in patients with obstructive sleep apnea treated with continuous positive airway pressure. Sleep Breath 16(2):393–398CrossRef
15.
16.
Zurück zum Zitat Itzhaki S, Dorchin H, Clark G, Lavie L, Lavie P, Pillar G (2007) The effects of 1-year treatment with a herbst mandibular advancement splint on obstructive sleep apnea, oxidative stress, and endothelial function. Chest 131(3):740–749CrossRef Itzhaki S, Dorchin H, Clark G, Lavie L, Lavie P, Pillar G (2007) The effects of 1-year treatment with a herbst mandibular advancement splint on obstructive sleep apnea, oxidative stress, and endothelial function. Chest 131(3):740–749CrossRef
17.
Zurück zum Zitat Bakan E, Fidan V, Alp H, Baygutalp N, Cokluk E (2015) Effect of modified fujita technique uvulopalatoplasty on oxidative DNA damage levels in patients with obstructive sleep apnea syndrome. J Craniofac Surg 26(5):e392–e396CrossRef Bakan E, Fidan V, Alp H, Baygutalp N, Cokluk E (2015) Effect of modified fujita technique uvulopalatoplasty on oxidative DNA damage levels in patients with obstructive sleep apnea syndrome. J Craniofac Surg 26(5):e392–e396CrossRef
18.
Zurück zum Zitat Vuralkan E, Mutlu M, Fırat I, Akaydin S, Sagit M, Akin I, Miser E, Ardic S (2013) Changes in serum levels of MDA and MMP-9 after UPF in patients with OSAS. Eur Arch Otorhinolaryngol 271(5):1329–1334CrossRef Vuralkan E, Mutlu M, Fırat I, Akaydin S, Sagit M, Akin I, Miser E, Ardic S (2013) Changes in serum levels of MDA and MMP-9 after UPF in patients with OSAS. Eur Arch Otorhinolaryngol 271(5):1329–1334CrossRef
19.
Zurück zum Zitat Dal-Fabbro C, Garbuio S, D’Almeida V, Cintra F, Tufik S, Bittencourt L (2014) Mandibular advancement device and CPAP upon cardiovascular parameters in OSA. Sleep Breath 18(4):749–759CrossRef Dal-Fabbro C, Garbuio S, D’Almeida V, Cintra F, Tufik S, Bittencourt L (2014) Mandibular advancement device and CPAP upon cardiovascular parameters in OSA. Sleep Breath 18(4):749–759CrossRef
20.
Zurück zum Zitat Cho J, Suh J, Kim Y, Hong S, Kim I, Kim J (2015) Reduction in oxidative stress biomarkers after adenotonsillectomy. Int J Pediatr Otorhinolaryngol 79(9):1408–1411CrossRef Cho J, Suh J, Kim Y, Hong S, Kim I, Kim J (2015) Reduction in oxidative stress biomarkers after adenotonsillectomy. Int J Pediatr Otorhinolaryngol 79(9):1408–1411CrossRef
Metadaten
Titel
Assessment of the relationship between polysomnography parameters and plasma malondialdehyde levels in patients with obstructive sleep apnea
verfasst von
Özden Savaş
Ahmet Emre Süslü
Incilay Lay
Serdar Özer
Publikationsdatum
01.07.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
European Archives of Oto-Rhino-Laryngology / Ausgabe 12/2019
Print ISSN: 0937-4477
Elektronische ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-019-05536-z

Weitere Artikel der Ausgabe 12/2019

European Archives of Oto-Rhino-Laryngology 12/2019 Zur Ausgabe

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.